doi: 10.3390/antiox13121529, 23 ConradM.PronethB
I wonder how they can square this with the ASA guidelines Each specialty society has their own guidelines and position statements
Novo Nordisk A/S: Wegovy HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss [Press release]
Originally FDA-approved for type 2 diabetes, Ozempic is the same semaglutide molecule as Wegovy but at different dose strengths (0.25mg, 0.5mg, 1mg, 2mg)
Among covered workers in plans with three or more tiers of cost sharing for prescription drugs, the average coinsurance rate is 19% for first-tier drugs, 25% for second-tier drugs, 35% for third-tier drugs, and 31% for fourth-tier drugs [Figure 9.6]
Patients should discuss their weight loss goals and expectations with their healthcare provider to ensure that they are on track to achieve the desired outcomes